Rock Creek Group, LP Danaher Corp Transaction History

Rock Creek Group, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$233.08 - $265.59 $22,142 - $25,231	-95 Reduced 12.68%	654 $162,000
Q2 2023 Aug 09, 2023	BUY	$224.99 - $256.14 $27,898 - $31,761	124 Added 19.84%	749 $179,000
Q1 2023 May 10, 2023	BUY	$239.75 - $277.0 $51,786 - $59,832	216 Added 52.81%	625 $157,000
Q4 2022 Feb 13, 2023	BUY	$241.42 - $282.29 $11,588 - $13,549	48 Added 13.3%	409 $108,000
Q3 2022 Nov 10, 2022	SELL	$247.06 - $1507.4 $10,870 - $66,325	-44 Reduced 10.86%	361 $93,000
Q2 2022 Aug 08, 2022	SELL	$237.11 - $299.66 $79,194 - $100,086	-334 Reduced 45.2%	405 $103,000
Q1 2022 May 11, 2022	SELL	$257.27 - $315.76 $24,955 - $30,628	-97 Reduced 11.6%	739 $217,000
Q4 2021 Feb 11, 2022	SELL	$292.08 - $329.01 $23,658 - $26,649	-81 Reduced 8.83%	836 $275,000
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $151,076 - $184,498	-555 Reduced 37.7%	917 $279,000
Q2 2021 Aug 10, 2021	BUY	$225.08 - $271.69 $42,315 - $51,077	188 Added 14.64%	1,472 $395,000
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $413,928 - $479,259	-1,949 Reduced 60.28%	1,284 $289,000
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $131,325 - $151,694	618 Added 23.63%	3,233 $718,000
Q3 2020 Oct 30, 2020	SELL	$177.16 - $215.33 $98,500 - $119,723	-556 Reduced 17.53%	2,615 $563,000
Q2 2020 Aug 13, 2020	SELL	$128.7 - $176.83 $1.93 Million - $2.65 Million	-15,006 Reduced 82.55%	3,171 $561,000
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $2.21 Million - $3.07 Million	18,177 New	18,177 $926,000

2,510

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

Stay updated on Rock Creek Group, LP with notifications on news.